These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30240750)

  • 1. Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
    Chatterjee A; Rodger EJ; Ahn A; Stockwell PA; Parry M; Motwani J; Gallagher SJ; Shklovskaya E; Tiffen J; Eccles MR; Hersey P
    iScience; 2018 Jun; 4():312-325. PubMed ID: 30240750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Reprogramming and Constitutive PD-L1 Expression in Melanoma Are Associated with Dedifferentiation and Activation of Interferon and Tumour Necrosis Factor Signalling Pathways.
    Ahn A; Rodger EJ; Motwani J; Gimenez G; Stockwell PA; Parry M; Hersey P; Chatterjee A; Eccles MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
    Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.
    Madore J; Strbenac D; Vilain R; Menzies AM; Yang JY; Thompson JF; Long GV; Mann GJ; Scolyer RA; Wilmott JS
    Clin Cancer Res; 2016 Aug; 22(15):3915-23. PubMed ID: 26960397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.
    Emran AA; Chatterjee A; Rodger EJ; Tiffen JC; Gallagher SJ; Eccles MR; Hersey P
    Trends Immunol; 2019 Apr; 40(4):328-344. PubMed ID: 30853334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival.
    Micevic G; Thakral D; McGeary M; Bosenberg MW
    Pigment Cell Melanoma Res; 2019 May; 32(3):435-440. PubMed ID: 30343532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
    Larsen TV; Hussmann D; Nielsen AL
    Cancer Commun (Lond); 2019 Jun; 39(1):30. PubMed ID: 31159869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.
    Budczies J; Denkert C; Győrffy B; Schirmacher P; Stenzinger A
    BMC Med Genomics; 2017 Dec; 10(1):74. PubMed ID: 29212506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells.
    Lai Q; Wang H; Li A; Xu Y; Tang L; Chen Q; Zhang C; Gao Y; Song J; Du Z
    Oncogene; 2018 Apr; 37(17):2302-2312. PubMed ID: 29422611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
    Gowrishankar K; Gunatilake D; Gallagher SJ; Tiffen J; Rizos H; Hersey P
    PLoS One; 2015; 10(4):e0123410. PubMed ID: 25844720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.
    Botti G; Fratangelo F; Cerrone M; Liguori G; Cantile M; Anniciello AM; Scala S; D'Alterio C; Trimarco C; Ianaro A; Cirino G; Caracò C; Colombino M; Palmieri G; Pepe S; Ascierto PA; Sabbatino F; Scognamiglio G
    J Transl Med; 2017 Feb; 15(1):46. PubMed ID: 28231855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperativity of HOXA5 and STAT3 Is Critical for HDAC8 Inhibition-Mediated Transcriptional Activation of PD-L1 in Human Melanoma Cells.
    Wang YF; Liu F; Sherwin S; Farrelly M; Yan XG; Croft A; Liu T; Jin L; Zhang XD; Jiang CC
    J Invest Dermatol; 2018 Apr; 138(4):922-932. PubMed ID: 29174371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma.
    Kümpers C; Jokic M; Haase O; Offermann A; Vogel W; Grätz V; Langan EA; Perner S; Terheyden P
    Front Med (Lausanne); 2019; 6():27. PubMed ID: 30931305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
    Kakavand H; Rawson RV; Pupo GM; Yang JYH; Menzies AM; Carlino MS; Kefford RF; Howle JR; Saw RPM; Thompson JF; Wilmott JS; Long GV; Scolyer RA; Rizos H
    Clin Cancer Res; 2017 Oct; 23(20):6054-6061. PubMed ID: 28724663
    [No Abstract]   [Full Text] [Related]  

  • 16. Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.
    Vilain RE; Menzies AM; Wilmott JS; Kakavand H; Madore J; Guminski A; Liniker E; Kong BY; Cooper AJ; Howle JR; Saw RPM; Jakrot V; Lo S; Thompson JF; Carlino MS; Kefford RF; Long GV; Scolyer RA
    Clin Cancer Res; 2017 Sep; 23(17):5024-5033. PubMed ID: 28512174
    [No Abstract]   [Full Text] [Related]  

  • 17. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.
    Hays E; Bonavida B
    Drug Resist Updat; 2019 Mar; 43():10-28. PubMed ID: 31005030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma.
    Yeon M; Kim Y; Jung HS; Jeoung D
    Front Cell Dev Biol; 2020; 8():486. PubMed ID: 32626712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.
    Huang KC; Chiang SF; Chen WT; Chen TW; Hu CH; Yang PC; Ke TW; Chao KSC
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32079180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific zinc finger-induced methylation of PD-L1 promoter inhibits its expression.
    Li X; Wang Z; Huang J; Luo H; Zhu S; Yi H; Zheng L; Hu B; Yu L; Li L; Xie J; Zhu N
    FEBS Open Bio; 2019 Jun; 9(6):1063-1070. PubMed ID: 31090214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.